Hikma Pharmaceutical | HIK - Cash And Equivalent

Stock Price
1,552.00
Daily Change
-80.00 -4.90%
Monthly
-2.08%
Yearly
-32.35%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $236M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
argenx SE USD 4.3B 2.21B Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Autolus Therapeutics Ltd USD 86.12M 37.7M Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Galapagos EUR 64.46M 43.61M Sep/2025
Genmab DKK 1.3B 323M Jun/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Lonza CHF 1.11B 286M Dec/2024
Merck EUR 1.17B 161M Jun/2025
Orion EUR 224.2M 35.2M Sep/2025
Recordati EUR 341.55M 8.51M Jun/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
UCB EUR 1.57B 1.14B Dec/2024